89bio (ETNB) said late Tuesday it priced an underwritten public offering of 21.7 million common shares at $8.75 per share and, in lieu of common shares to a certain investor, pre-funded warrants to purchase up to 6.9 million shares for expected gross proceeds of $250 million.
The pre-funded warrants are priced at $8.749 apiece with an exercise price of $0.001 per share.
The underwriters have been granted a 30-day option to purchase up to 4.3 million additional shares.
Closing of the offering is expected to occur on Thursday, subject to customary conditions.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。